Tag: cabotegravir

EC approves Cabotegravir LA by ViiV Healthcare for HIV prevention

businessnewstoday- September 19, 2023

ViiV Healthcare, majorly owned by GSK with Pfizer and Shionogi as shareholders, announced that the European Commission (EC) has authorized Apretude, also known as cabotegravir ... Read More

ViiV Healthcare secures Cabenuva FDA approval for HIV-1 treatment

pharmanewsdaily- January 24, 2021

Cabenuva FDA approval : ViiV Healthcare has secured approval from the US Food and Drug Administration (FDA) for its long-acting regimen Cabenuva for the treatment ... Read More